Literature DB >> 23728782

Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas.

Antoine E Melkane1, Anne Auperin, Patrick Saulnier, Ludovic Lacroix, Philippe Vielh, Odile Casiraghi, Issam Msakni, Françoise Drusch, Stéphane Temam.   

Abstract

BACKGROUND: Human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (SCC) is associated with favorable survival. The purpose of this study was to evaluate the prevalence and prognostic significance of the HPV infection through both the p16 expression status and the oncogenic HPV DNA viral load.
METHODS: A retrospective chart review was conducted on all patients treated for oropharyngeal SCC between January 2007 and June 2009. P16 expression status by immunohistochemistry and HPV DNA viral load by quantitative polymerase chain reaction (qPCR) were evaluated on routine pretreatment tumor samples.
RESULTS: One hundred thirty-three patients (94 men and 39 women) were included in the study. Mean age was 59 years. One hundred twenty-two lesions (92%) were localized to lymphoid areas. Sixty-seven patients (50%) were p16+, and 87 patients (65%) harbored HPV DNA. The p16+/HPV DNA+ profile (48%) was associated with the most favorable prognosis. HPV16 was responsible for the majority of the infections (89%).
CONCLUSION: HPV is common among oropharyngeal SCC in France, and acts as an independent prognostic factor.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  human papillomavirus; oropharynx; p16; quantitative polymerase chain reaction; squamous cell carcinoma

Mesh:

Year:  2013        PMID: 23728782     DOI: 10.1002/hed.23302

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  14 in total

1.  New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.

Authors:  Kevin David Shield; Claire Marant Micallef; Catherine de Martel; Isabelle Heard; Francis Megraud; Martyn Plummer; Jérôme Vignat; Freddie Bray; Isabelle Soerjomataram
Journal:  Eur J Epidemiol       Date:  2017-12-06       Impact factor: 8.082

2.  Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.

Authors:  Annekatrin Coordes; Klaus Lenz; Xu Qian; Minoo Lenarz; Andreas M Kaufmann; Andreas E Albers
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-31       Impact factor: 2.503

3.  Tumoral Expression of CD44 and HIF1α Predict Stage I Oral Cavity Squamous Cell Carcinoma Outcome.

Authors:  Johannes Dunkel; Samuli Vaittinen; Petri Koivunen; Jussi Laranne; Markus J Mäkinen; Satu Tommola; Heikki Irjala
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-01-14

Review 4.  Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.

Authors:  Robbie Woods; Esther M O'Regan; Susan Kennedy; Cara Martin; John J O'Leary; Conrad Timon
Journal:  World J Clin Cases       Date:  2014-06-16       Impact factor: 1.337

5.  Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma.

Authors:  Alexey Surov; Hans Jonas Meyer; Anne-Kathrin Höhn; Karsten Winter; Osama Sabri; Sandra Purz
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

6.  Incidence trends for potentially human papillomavirus-related and -unrelated head and neck cancers in France using population-based cancer registries data: 1980-2012.

Authors:  Karine Jéhannin-Ligier; Aurélien Belot; Anne-Valérie Guizard; Nadine Bossard; Guy Launoy; Zoé Uhry
Journal:  Int J Cancer       Date:  2017-02-22       Impact factor: 7.396

7.  Methylation Status of P16Ink4a in Human Papillomavirus-Associated Cancer of Oral Cavity and Oropharynx in Northeastern Thailand

Authors:  Piyawut Swangphon; Chamsai Pientong; Ati Burassakarn; Patravoot Vatanasapt; Pilaiwan Kleebkaow; Natcha Patarapadungkit; Thanabut Treebupachatsakul; Supannee Promthet; Bunkerd Kongyingyoes; Tipaya Ekalaksananan
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

8.  DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma.

Authors:  Eric A Smith; Bhavna Kumar; Kakajan Komurov; Stephen M Smith; Nicole V Brown; Songzhu Zhao; Pawan Kumar; Theodoros N Teknos; Susanne I Wells
Journal:  Oncotarget       Date:  2017-04-04

9.  MET genetic abnormalities unreliable for patient selection for therapeutic intervention in oropharyngeal squamous cell carcinoma.

Authors:  Ludovic Lacroix; Sophie F Post; Alexander Valent; Antoine E Melkane; Philippe Vielh; Coumaran Egile; Christelle Castell; Christelle Larois; Sandrine Micallef; Patrick Saulnier; Hélène Goulaouic; Anne-Marie Lefebvre; Stéphane Temam
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

10.  Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype.

Authors:  Andreas E Albers; Xu Qian; Andreas M Kaufmann; Annekatrin Coordes
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.